Even though certain chemotherapeutic agents (i.e., anthracyclines) are used in the initial treatment of both ALL and AML, it should also be emphasized that the prognostic impact of SET-NUP214 may depend on the biological context, and thereby differ between T-ALL and AML. The gene discussed is NUP214; the disease is acute myeloid leukemia.